Correspondence 0001437749-24-027905 from EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC.
Date: Aug. 28, 2024 · CIK: 0001549084 · Accession: 0001437749-24-027905
AI Filing Summary & Sentiment
File numbers found in text: 333-281081
Letter
ekso20240828_corresp.htm
August 28, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Edwin Kim
Re:
Ekso Bionics Holdings, Inc.
Registration Statement on Form S-1
File No. 333-281081
Acceleration Request
Requested Date:
August 29, 2024
Requested Time:
4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ekso Bionics Holdings, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-281081) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.
Sincerely,
EKSO BIONICS HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm ekso20240828_corresp.htm August 28, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Edwin Kim Re: Ekso Bionics Holdings, Inc. Registration Statement on Form S-1 File No. 333-281081 Acceleration Request Requested Date: August 29, 2024 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ekso Bionics Holdings, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-281081) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410. Sincerely, EKSO BIONICS HOLDINGS, INC. By: /s/ Scott G. Davis Scott G. Davis Chief Executive Officer cc: Mark B. Baudler, Wilson Sonsini Goodrich & Rosati Austin D. March, Wilson Sonsini Goodrich & Rosati